Chris Heberlig

Chris Heberlig has an estimated net worth of $3.33 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., ORGANOVO HOLDINGS, INC., and SYNAGEVA BIOPHARMA CORP.

2012 was Chris Heberlig's most active year for acquiring shares with 7 total transactions. Chris Heberlig's most active month to acquire stocks was the month of May. 2012 was Chris Heberlig's most active year for disposing of shares, totalling 15 transactions. Chris Heberlig's most active month to dispose stocks was the month of February. 2015 saw Chris Heberlig paying a total of $316,578.40 for 31,642 shares, this is the most they've acquired in one year. In 2014 Chris Heberlig cashed out on 27,540 shares for a total of $1,311,962.69, their largest year based on trade value.